Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis

PH Nguyen, A Ramamoorthy, BR Sahoo… - Chemical …, 2021 - ACS Publications
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …

Congo Red and amyloids: history and relationship

EI Yakupova, LG Bobyleva, IM Vikhlyantsev… - Bioscience …, 2019 - portlandpress.com
Abstract Staining with Congo Red (CR) is a qualitative method used for the identification of
amyloids in vitro and in tissue sections. However, the drawbacks and artefacts obtained …

Microglial amyloid beta clearance is driven by PIEZO1 channels

H Jäntti, V Sitnikova, Y Ishchenko… - Journal of …, 2022 - Springer
Background Microglia are the endogenous immune cells of the brain and act as sensors of
pathology to maintain brain homeostasis and eliminate potential threats. In Alzheimer's …

Role of natural products for the treatment of Alzheimer's disease

T Noori, AR Dehpour, A Sureda… - European journal of …, 2021 - Elsevier
Negative psychological and physiological consequences of neurodegenerative disorders
represent a high social and health cost. Among the neurodegenerative disorders …

Alzheimer's disease and type 2 diabetes: a critical assessment of the shared pathological traits

S Chatterjee, A Mudher - Frontiers in neuroscience, 2018 - frontiersin.org
Alzheimer's disease (AD) and Type 2 Diabetes Mellitus (T2DM) are two of the most
prevalent diseases in the elderly population worldwide. A growing body of epidemiological …

Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer's disease brains

AM Stern, Y Yang, S **, K Yamashita, AL Meunier… - Neuron, 2023 - cell.com
Soluble oligomers of amyloid β-protein (Aβ) have been defined as aggregates in
supernatants following ultracentrifugation of aqueous extracts from Alzheimer's disease (AD) …

PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins

GT Corbett, Z Wang, W Hong, M Colom-Cadena… - Acta …, 2020 - Springer
Neurodegenerative diseases are an enormous public health problem, affecting tens of
millions of people worldwide. Nearly all of these diseases are characterized by …

Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of β-amyloidosis

TPV Huynh, F Liao, CM Francis, GO Robinson… - Neuron, 2017 - cell.com
The apolipoprotein E (APOE) gene is the strongest genetic risk factor for late-onset
Alzheimer disease. Previous studies suggest that reduction of apoE levels through genetic …

[HTML][HTML] Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins: Thematic Review Series: ApoE …

TPV Huynh, AA Davis, JD Ulrich, DM Holtzman - Journal of lipid research, 2017 - Elsevier
Alzheimer's disease (AD) is one of the fastest-growing causes of death and disability in
persons 65 years of age or older, affecting more than 5 million Americans alone. Clinical …

Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils

M Muschol, W Hoyer - Frontiers in molecular biosciences, 2023 - frontiersin.org
Amyloid Diseases involve the growth of disease specific proteins into amyloid fibrils and
their deposition in protein plaques. Amyloid fibril formation is typically preceded by …